Search Results

The Safe-Steer™ Guide Wire System is indicated for use in facilitating the placement of catheters used in percutaneous interventions in native coronary arteries with total occlusions.

The Safe-Steer™ Guide Wire System consists of the following:

• Safe-Steer™ 0.014" Guide Wire ●
• Safe-Steer™ OCR Unit with Display Monitor .
  The Safe-Steer™ Guide Wire is similar to a conventional 0.014" coronary guide wire, except that it incorporates an optic fiber, which runs the length of the guide wire. The Safe-Steer™ Guide Wire is connected to the OCR Unit, providing information on the Display Monitor of the location of the distal tip relative to the vessel wall.

The provided text is related to a 510(k) submission for a medical device called the Safe-Steer™ Guide Wire System. This submission describes a modification to an existing cleared device and asserts substantial equivalence to its predicate device. This type of submission relies on demonstrating that the modified device performs as safely and effectively as the predicate, often through performance testing and biocompatibility.

However, the provided document does not contain the detailed information required to answer all parts of your request, especially regarding clinical study specifics like sample size, reader qualifications, or ground truth establishment in the context of diagnostic or prognostic performance. The device is a guide wire, which is an interventional tool, not an AI/ML diagnostic algorithm.

Here's a breakdown of what can be extracted and what cannot:

1. A table of acceptance criteria and the reported device performance

The document states: "The Safe-Steer Guide Wire has been subjected to performance testing to verify conformance to the requirements of the product specification." and "On the basis of the testing conducted on the Safe-Steer™ Guide Wire it may be concluded that the device satisfies safety and performance requirements when used in accordance with the Instructions for Use for the indicated patient population."

However, specific acceptance criteria values and reported performance metrics are NOT provided in this summary. For a guide wire, performance criteria would typically include:

• Mechanical Properties: Tensile strength, torque response, pushability, trackability, flexibility, kink resistance, tip integrity.
• Biocompatibility: Confirmation of non-toxic, non-irritating, non-sensitizing properties, often tested according to ISO 10993 standards.
• Dimensional Accuracy: Outer diameter, length, and other critical dimensions as per specifications.
• Integrity of Components: E.g., for this device, the integrity of the optic fiber within the guide wire.
• Connection/System Functionality: For the Safe-Steer™ system, this would include the OCR Unit's ability to accurately display the distal tip's location relative to the vessel wall.

Due to the lack of specific data in the provided text, a table can only indicate the types of testing performed, not quantitative results or acceptance thresholds.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

This information is not provided. The text mentions "performance testing" and "biocompatibility testing" but does not detail the sample sizes for these tests, nor does it specify if any human clinical data (which implies provenance) was used for this particular modification. Given it's a device modification and a special 510(k), the primary focus would be on bench and possibly pre-clinical (animal) testing to confirm the changes don't adversely affect performance.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This is not applicable or provided. The device is an interventional guide wire, not an AI diagnostic tool requiring expert interpretation for ground truth establishment. The performance testing would involve engineering and laboratory methods, not expert clinical readers interpreting outputs.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable or provided. Since the device is a medical instrument (guide wire), not a diagnostic algorithm where human interpretation and adjudication are involved in a test set, this concept doesn't apply.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This information is not applicable or provided. The device is an interventional guide wire with an optical coherence reflectometry (OCR) unit to help locate its tip. It's not an AI-powered diagnostic tool, and therefore, an MRMC study and AI assistance effect size are not relevant in this context.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is not applicable or provided. The Safe-Steer™ Guide Wire System is a physical medical device, not a standalone algorithm. While the OCR unit processes data, its functionality is integrated into the guide wire's use by a clinician, meaning there is always a "human-in-the-loop."

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The concept of "ground truth" as typically applied to diagnostic AI algorithms (e.g., pathology for cancer detection) does not directly apply here. For a guide wire, the "truth" would be established through:

• Bench Test Standards: Adherence to engineering specifications and performance benchmarks (e.g., does it meet specified torque, trackability, or tensile strength values under defined conditions?).
• Biocompatibility Testing Standards: Compliance with ISO 10993 series through laboratory assays.
• Physical Measurement: Actual measurements (e.g., diameter, length) compared to design specifications.
• Functional Verification: For the OCR unit, verifying that the display accurately reflects the physical location of the guide wire tip as measured by other independent means (e.g., visual inspection in phantoms, specialized sensors).

8. The sample size for the training set

This information is not applicable or provided. This is not an AI/ML device that requires training data.

9. How the ground truth for the training set was established

This information is not applicable or provided. As above, it is not an AI/ML device.

Ask a specific question about this device

The Safe-Steer™ Guide Wire System is indicated for use in facilitating the placement of catheters used in percutaneous interventions in native coronary arteries with total occlusions.

The IntraLuminal Therapeutics, Inc. SAFE-STEER™ Guide Wire System is comprised of a sterile single-use guide wire with an integrated optical fiber. The guide wire is used with a support catheter of choice that will accommodate a .014" guidewire. The optical fiber in the guide wire is connected to a reusable Optical Coherence Reflectometry (OCR). The guide wire core has an embedded optical fiber that transmits near infrared light and the reflection is relayed back to the OCR unit and then a unique intensity versus distance measurement is exhibited on the OCR display. The trace of the slope on the OCR display distinguishes the distance from the tip of the wire and the vessel wall. The display output exhibits the relative distance between the wire tip and vessel wall. The guide wire is provided in lengths of 175 cm and 275 cm long and has a diameter of 0.014" with a lubricious hydrophilic coating in the distal region. The guide wire is sterilized by ethylene oxide and packaged to maintain the sterile barrier.

The provided document is a 510(k) premarket notification for the SAFE-STEER™ Guide Wire System. It details the device, its intended use, and claims substantial equivalence to predicate devices, but it does not contain acceptance criteria or a study designed to prove the device meets specific performance criteria.

Instead, the document states that "Safety and performance testing was performed to demonstrate that the IntraLuminal Therapeutics SAFE-STEER™ Guide Wire System is substantially equivalent to the predicate devices." It then broadly lists the types of testing conducted: "software, performance, biocompatibility, packaging, clinical and comparative tests."

Therefore, I cannot extract the requested information as it is not present in the provided text. The document concludes with a claim of substantial equivalence and meeting internal product specifications, rather than reporting against specific, publicly available acceptance criteria.

Ask a specific question about this device